Andrew Moshfeghi, MD, MBA, associate professor of clinical ophthalmology at the USC Roski Eye Institute, is spotlighted in Diabetes Series Live’s latest entry in its Diabetic Retinopathy Virtual CME Series – Game-Changing Therapeutic Advances in Diabetic Retinopathy. This free video can be viewed live online as a continuing medical education initiative. The video discusses brand new advances in diabetic retinopathy treatments and includes a real-time Q&A online. In addition, those who view the CME will earn AMA PRA Category 1 Credit.
To watch the CME, click here.
Dr. Moshfeghi and Featured Speaker Dean Eliott, MD, associate director, from Massachusetts Eye and Ear Retina Service, will discuss topics including:
– What role vascular endothelial growth factor (VEGF) plays in ocular neovascularization
– The benefits of anti-VEGF therapy for diabetic retinopathy
– Anti-VEGF therapy and laser treatment efficacy comparison
– Techniques for intravitreal injection and complication management
Dr. Moshfeghi will participate in another live streaming CME on October 7th at 2pm with Diabetes Series Live – Achieving Better Outcomes for Patients with Diabetic Retinopathy: The Expanding Role of the Ophthalmologist. This CME will include Timothy Murtha, MD, of Harvard Medical School.
In addition, we are proud to announce the debut of our brand new website at eye.keckmedicine.org. Please visit our site and find in-depth information on our physicians, staff, treatments, education, and countless advancements being made in the field of ophthalmology.
Keck School of Medicine of USC
Professor and Chair
USC Department of Ophthalmology
Director, USC Roski Eye Institute